|
Sharma, Sai Kiran; Chow, Andrew; Monette, Sebastien et al. (2018) Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Res 78:1820-1832
|
|
Untch, Brian R; Dos Anjos, Vanessa; Garcia-Rendueles, Maria E R et al. (2018) Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers. Cancer Res 78:4642-4657
|
|
Maus, Marcela V; Plotkin, Jason; Jakka, Gopinadh et al. (2016) An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity. Mol Ther Oncolytics 3:1-9
|
|
Viny, Aaron D; Ott, Christopher J; Spitzer, Barbara et al. (2015) Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis. J Exp Med 212:1819-32
|
|
Callahan, Margaret K; Masters, Gregg; Pratilas, Christine A et al. (2014) Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor. Cancer Immunol Res 2:70-9
|
|
Snyder, Alexandra; Makarov, Vladimir; Merghoub, Taha et al. (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189-2199
|
|
Diab, Adi; Jenq, Robert R; Rizzuto, Gabrielle A et al. (2013) Enhanced responses to tumor immunization following total body irradiation are time-dependent. PLoS One 8:e82496
|
|
Rizzuto, Gabrielle A; Merghoub, Taha; Hirschhorn-Cymerman, Daniel et al. (2009) Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. J Exp Med 206:849-66
|
|
Marcucci, Guido; Maharry, Kati; Radmacher, Michael D et al. (2008) Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 26:5078-87
|
|
Marcucci, Guido; Maharry, Kati; Whitman, Susan P et al. (2007) High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 25:3337-43
|
Showing the most recent 10 out of 115 publications
